An inseparable part of healthy aging

Sexual longevity is the joint evaluation of hormonal, vascular, neurological, metabolic, and psychosocial factors that affect sexual desire, function, genital comfort, and quality of life. The goal is not to apply the same rejuvenation procedure to everyone, but to identify measurable problems and modifiable risks.

Menopause and genital tissue health

Genitourinary syndrome of menopause (GSM), associated with decreased estrogen, may present with dryness, burning, irritation, painful intercourse, and certain urinary symptoms. The evaluation also rules out infection, dermatological disease, vulvodynia, and other causes of pain. Options such as lubricants, vaginal moisturizers, and, in appropriate patients, low-dose vaginal estrogen have stronger clinical evidence. Treatment selection is made based on the individual’s medical history and contraindications.

Desire, arousal, orgasm, and pain

Sleep, chronic stress, relational factors, medications, and hormonal and metabolic status are addressed together. In persistent and distressing decreased sexual desire, psychosexual evaluation is important. For dyspareunia, superficial versus deep pain, pelvic floor muscle tone, and gynecological findings are differentiated; when necessary, patients are referred to gynecology and pelvic floor physical therapy.

Personalized female sexual health program

1. Initial consultation: symptom history, menopause and obstetric history, medications, expectations, and privacy.
2. Targeted evaluation: metabolic/hormonal tests according to clinical indication, gynecological evaluation, and pain and pelvic floor examination.
3. Plan: evidence-based local treatments for GSM; in appropriate cases, pain management, pelvic physical therapy, psychosexual support, and lifestyle optimization.
4. Follow-up: scales such as FSFI/FSDS-R in the appropriate context, 0–10 pain score, dryness, and daily living comfort; follow-up at 6–12 weeks and further follow-up as needed.

When is a specialist evaluation required?

In cases of postmenopausal bleeding, unexplained genital lesions, severe or progressive pain, and signs of infection, the priority is evaluation by the relevant medical specialty. Laser or other energy-based procedures are not a routine first-line option.

Technologies in our clinic: for what purpose do we evaluate them?

QEEG and neurofeedback: May be used according to the clinical context in evaluating accompanying issues such as sleep, stress, attention, and self-regulation. There is no established evidence for the direct treatment of sexual dysfunctions; QEEG alone does not diagnose a sexual disorder.

Ozone therapy: It is a method in which our clinic has application experience. However, it is not a standard treatment with proven efficacy in female or male sexual dysfunctions; we do not promise outcomes of increased circulation or genital rejuvenation.

Bioresonance: It is among the supportive technologies used in our clinic; since there is no reliable clinical evidence in the diagnosis or treatment of sexual dysfunctions, it is not positioned as a replacement for standard diagnosis and treatment.

980/1470 nm diode laser: There are small, uncontrolled clinical studies on female genital tissues. The wavelength of the device alone does not ensure suitability; genital use is not planned without verifying the applicator, energy distribution, manufacturer indication, and safety. There is no validated protocol for erectile dysfunction or penile rejuvenation in men.

Frequently asked questions

Are sexual health problems solely related to aging?

No. Medications, chronic diseases, hormones, stress, and relational factors can play a role.

Are the devices in your clinic a standalone solution?

No. Ozone, bioresonance, and neurofeedback are not proven direct treatments for sexual dysfunctions. The priority is accurate diagnosis and evidence-based options.

Is vaginal laser suitable for every woman?

No. A standard rejuvenation procedure is not recommended without a clinical indication and safety evaluation.

Scientific basis and level of evidence

Strong/established clinical approach: Cause-oriented evaluation, management of cardiometabolic risks, pharmacological treatments according to indication, local treatments for GSM, and pelvic floor rehabilitation.

In selected patients/conditional: Sex therapy, collaboration with relevant specialties, and certain interventional treatments.

Insufficient or investigational: Ozone, bioresonance, neurofeedback, and 980/1470 nm laser applications for sexual dysfunctions.

Sources: EAU Sexual and Reproductive Health Guidelines; AUA Clinical Guidelines; The Menopause Society; PubMed. Last updated: October 2026.